Ankylosing Spondylitis Trial, Recruiting (NCT05592574)

Ankylosing Spondylitis Trial, Recruiting NCT05592574 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Ankylosing Spondylitis

Printed from Voxsanity (voxsanity.com.au) — NCT05592574 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ankylosing Spondylitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You have been diagnosed with a condition called spondyloarthritis, confirmed using a recognised set of medical guidelines called the ASAS criteria.
Your doctor has decided you need to start a biological treatment (a type of medication made from living cells) because at least two common anti-inflammatory painkiller medicines have not worked well enough for you.
Your condition is currently considered active, meaning your symptoms are significantly affecting you, as shown by a score higher than 4 on a standard symptom questionnaire called the BASDAI.

Who may not be able to join:

Your main symptoms do not primarily affect your spine and back (confirm with trial site).
You have already received a biological treatment at any point in the past.
You have a medical reason why you cannot safely take the biological treatments being used in this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33492035491

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05592574

Sponsor: Centre Hospitalier Universitaire de Nice

Phase: Not Applicable

Status: Recruiting

Condition: Ankylosing Spondylitis

Trial contact: +33492035491

More information: https://clinicaltrials.gov/study/NCT05592574

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You have been diagnosed with a condition called spondyloarthritis, confirmed using a recognised set of medical guidelines called the ASAS criteria.
Your doctor has decided you need to start a biological treatment (a type of medication made from living cells) because at least two common anti-inflammatory painkiller medicines have not worked well enough for you.
Your condition is currently considered active, meaning your symptoms are significantly affecting you, as shown by a score higher than 4 on a standard symptom questionnaire called the BASDAI.

Who may not be able to join:

Your main symptoms do not primarily affect your spine and back (confirm with trial site).
You have already received a biological treatment at any point in the past.
You have a medical reason why you cannot safely take the biological treatments being used in this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Nice

Registry

ClinicalTrials.gov

Start date

1 February 2021

Est. completion

31 January 2041

Where this trial is recruiting

🇫🇷 France

Primary endpoints

to show the feasibility of cytokine assay following lymphocyte stimulation in active SpA requiring biological treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov